Skip to main content
TAK
NYSE Life Sciences

Takeda Refiles Shelf Registration for JPY 240B Long-Term Incentive Plan, Expects 1.1% Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$15.35
Mkt Cap
$50.927B
52W Low
$12.99
52W High
$18.895
52W Position info
18% above low
Off High info
19% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

TAK sits 18% above its 52-week low of $12.99.

Summary

Takeda refiled a shelf registration in Japan to facilitate its Long Term Incentive Plan, anticipating approximately 1.1% share dilution for FY2027.


Key Events · Financing and Capital Events · TAK

  • Shelf Registration Refiled

    Takeda withdrew its previous shelf registration and filed a new one in Japan, effective from June 9, 2026, for a one-year period.

  • Purpose for Long Term Incentive Plan

    The registration is specifically for issuing new shares or disposing of treasury shares to support the company's Long Term Incentive Plan (LTIP), not for raising new capital.

  • Maximum Share Amount

    The new shelf registration covers up to JPY 240 billion in shares, representing the estimated maximum total of LTIP units to vest and be granted.

  • Expected Share Dilution

    The company anticipates approximately 1.1% share dilution during the fiscal year ending March 31, 2027, due to the LTIP and other stock grant systems.


Analysis · TAK · Life Sciences

Takeda has refiled a shelf registration in Japan to facilitate its Long Term Incentive Plan (LTIP). This action allows the company to issue new shares or dispose of treasury shares over the next year for employee compensation, rather than for raising capital. While a standard corporate practice, the expected 1.1% share dilution for the fiscal year ending March 31, 2027, is a notable increase in the outstanding share count.

At the time of this filing, TAK was trading at $15.35 on NYSE in the Life Sciences sector, with a market capitalization of approximately $50.9B. The 52-week trading range was $12.99 to $18.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TAK - Latest Insights

TAK
Jul 13, 2026, 6:07 AM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $16.37
Real-time Price: $17.02 info
Change: +$0.654 (+4%) info
Market Cap: $55.015B info
TAK
Jun 29, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $15.98
Real-time Price: $17.02 info
Change: +$1.04 (+7%) info
Market Cap: $55.015B info
TAK
Jun 24, 2026, 6:14 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $15.84
Real-time Price: $17.02 info
Change: +$1.18 (+7%) info
Market Cap: $55.015B info
TAK
Jun 24, 2026, 6:06 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.84
Real-time Price: $17.02 info
Change: +$1.18 (+7%) info
Market Cap: $55.015B info
TAK
Jun 17, 2026, 6:06 AM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $15.64
Real-time Price: $17.02 info
Change: +$1.38 (+9%) info
Market Cap: $55.015B info